Pycnogenol for chronic venous insufficiency

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2011 English Publisher:Oxford University Press (OUP)Journal:American Journal of Health-System Pharmacy, volume 68, pages 1,589-1,601 (issn: 1079-2082, eissn: 1535-2900,

Copyright policy )

Authors: Donald S, Nuzum; Tsion T, Gebru; Samir A, Kouzi;

doi: 10.2146/ajhp100676

pmid: 21856804

Pycnogenol for chronic venous insufficiency

- Summary
- Subjects
- Metrics

Abstract

Chronic venous insufficiency (CVI) is a vascular disorder affecting 1–5% of the population and is most common in the elderly.[1][1],[2][2] Complications of CVI include edema and venous stasis ulcers, which can contribute to increased morbidity and health care costs.[3][3],[4][4] Unfortunately, few

Related Organizations

College of Health Sciences, Bahrain
Bahrain
Wingate University
United States

Keywords

Flavonoids, Dose-Response Relationship, Drug, Venous Insufficiency, Plant Extracts, Chronic Disease, Humans, Drug Interactions, Pinus

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	11
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%